Share this page:
RECENT POSTS
Sending Secure E-Mail at MedStar
It is important that all associates understand when it is necessary to encrypt the data Read More »
Read More »
Extension of the Effective Date of the Single IRB Policy for NIH Studies
As announced in the July edition of Focus, the National Institutes of Health (NIH) has Read More »
Read More »
Important Updates to Common Rule for Clinical Trials
U.S. Department of Health and Human Services (DHHS) and 15 other federal agencies on January Read More »
Read More »
New Final Guidance from the FDA on Electronic Informed Consent
Final guidance was published on December 15 by the U.S. Food and Drug Administration (FDA) Read More »
Read More »
Reporting Compliance Concerns
MedStar Health is committed to supporting the requirements of a high-reliability organization. In order for Read More »
Read More »
New Policy on Good Clinical Practice Training for NIH-Funded Clinical Trials
The NIH has released a new policy on training in Good Clinical Practices (GCP) for Read More »
Read More »
New HHS Final Rule and NIH Policy on Releasing Study Results on ClinicalTrials.gov
Released on September 16, the U.S. Department of Health and Human Services (HHS) issued a Read More »
Read More »
New HHS Guidance for HIPAA and Ransomware
The U.S. Department of Health and Human Services (HHS) has released a new guidance on ransomware and Read More »
Read More »
Final NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
The National Institutes of Health (NIH) has released a new policy, effective in 2017, to Read More »
Read More »
FDA Finalizes Three Guidances on Expanded Access to Investigational Drugs
Expanded access is the process by which investigational treatment options are made available to patients Read More »
Read More »